Epidemiology of nosocomial pneumonia (NP) in patients of general surgical departments Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005
Differences in clinical courses of nosocomial pneumonia between patients of surgical and therapeutic departments Source: Eur Respir J 2006; 28: Suppl. 50, 787s Year: 2006
Prevalence of nosocomial pneumonia in patients of the general surgical departments Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008
Emergency treatment of communityacquired pneumonia Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183 Year: 2006
Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease Source: International Congress 2019 – M-health/e-health I Year: 2019
Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
An influence of informational and educational prevention arrangements (IEA) of nosocomial pneumonia (NP) carried out among the surgeons on the NP level in general surgical departments (GSD) Source: Eur Respir J 2005; 26: Suppl. 49, 188s Year: 2005
The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 733s Year: 2006
Clinical stability in patients with community- acquired pneumonia (CAP) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
The usage of laferon in treatment of patients with community acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Prevalence, complications and evolution of community acquired pneumonia (CAP) in children in a secondary hospital in Brazil – 4 year‘s experience Source: Eur Respir J 2006; 28: Suppl. 50, 494s Year: 2006
Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD) Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002